IVIG shows no impact on VTE risk in dermatomyositis patientsMay 11, 2023Lupus & Connective Tissue Diseases
Low disease state for childhood lupus approaches validationMay 10, 2023Lupus & Connective Tissue DiseasesPediatrics
Researchers seek to understand post-COVID autoimmune disease riskMay 1, 2023COVID-19 UpdatesLong COVIDRheumatoid ArthritisLupus & Connective Tissue Diseases
Cocaine damage can be misdiagnosed as nasal vasculitisApril 17, 2023Lupus & Connective Tissue Diseases
Antiphospholipid antibodies linked to future CV eventsApril 11, 2023Lupus & Connective Tissue Diseases
Childhood lupus severity linked to social determinants of healthApril 4, 2023PediatricsLupus & Connective Tissue Diseases
New coalition aims to revolutionize stalled lupus researchMarch 30, 2023Lupus & Connective Tissue Diseases
Biosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicineRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsLupus & Connective Tissue DiseasesAnkylosing spondylitis
Anifrolumab shows promise in refractory discoid lupus erythematosusMarch 27, 2023Lupus & Connective Tissue Diseases
CT results in myositis inform cancer screening strategiesMarch 24, 2023Lupus & Connective Tissue Diseases
Novel therapy shows promise for treating skin-predominant dermatomyositisMarch 21, 2023Lupus & Connective Tissue Diseases
Experts share early details prescribing avacopan for ANCA-associated vasculitisMarch 14, 2023Lupus & Connective Tissue Diseases
